A Role for DNA Methylation in Regulating the Growth Suppressor PMEPA1 Gene in Prostate Cancer
暂无分享,去创建一个
S. Srivastava | Hongyun Li | M. Ehrich | A. Dobi | Shiv Srivastava | Mathias Ehrich | E. Richter | K. Masuda | Christopher Cook | A. Tadese | A. Owusu | Albert Dobi | Christopher Cook | Katsuaki Masuda | Eric Richter | Atekelt Y Tadese | Hongyun Li | Anthony Owusu | C. Cook
[1] A. D. De Marzo,et al. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer , 2004, Journal of cellular biochemistry.
[2] R. Vessella,et al. Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.
[3] T. Guthrie,et al. Prostate cancer. , 2020, American family physician.
[4] S. Abdulkadir,et al. Notch Signaling and ERK Activation Are Important for the Osteomimetic Properties of Prostate Cancer Bone Metastatic Cell Lines* , 2004, Journal of Biological Chemistry.
[5] C. Bieberich,et al. Prostate-specific and Androgen-dependent Expression of a Novel Homeobox Gene* , 1996, The Journal of Biological Chemistry.
[6] J. Christman,et al. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy , 2002, Oncogene.
[7] J. Clements,et al. Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors , 2001, Molecular carcinogenesis.
[8] Simon A. Williams,et al. Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer? , 2007, The Prostate.
[9] Jeanne Kowalski,et al. Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer , 2004, Cancer Research.
[10] Weihua Ni,et al. OAZ Regulates Bone Morphogenetic Protein Signaling through Smad6 Activation* , 2006, Journal of Biological Chemistry.
[11] S. Srivastava,et al. Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival , 2006, Oncogene.
[12] David A Jones,et al. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine. , 2004, Molecular pharmacology.
[13] Wei Zhang,et al. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. , 2003, Cancer research.
[14] P. Nguyen,et al. The epigenome as a molecular marker and target , 2005, Cancer.
[15] S. Arya,et al. The LNCaP cell line--a new model for studies on human prostatic carcinoma. , 1980, Progress in clinical and biological research.
[16] Kirsten L. Greene,et al. CpG methylation at promoter site −140 inactivates TGFβ2 receptor gene in prostate cancer , 2005, Cancer.
[17] Manel Esteller,et al. The necessity of a human epigenome project. , 2006, Carcinogenesis.
[18] R. Singal,et al. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. , 2001, Cancer research.
[19] A. Hata,et al. Poly(ADP-ribose) polymerase 1 interacts with OAZ and regulates BMP-target genes. , 2003, Biochemical and biophysical research communications.
[20] W. Schulz,et al. Epigenetics of prostate cancer: beyond DNA methylation , 2006, Journal of cellular and molecular medicine.
[21] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[22] Matthias Frisch,et al. Androgen receptor binding sites identified by a GREF_GATA model. , 2005, Journal of molecular biology.
[23] J. Lutterbaugh,et al. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. , 2003, Cancer research.
[24] Ximing J. Yang,et al. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP). , 2005, Molecular endocrinology.
[25] John K Field,et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] Yusuke Nakamura,et al. Identification of STAG1 as a key mediator of a p53-dependent apoptotic pathway , 2004, Oncogene.
[27] Thomas Werner,et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..
[28] J W Moul,et al. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. , 2000, Genomics.